OPRX_logo

SURVEY RESULTS ARE IN:

Oncologists reveal why ALK+ NSCLC patients switch or discontinue treatment

Download your copy of the report today to explore the factors that lead to treatment discontinuation, as well as how oncologists rank currently available ALK+ NSCLC treatments, so you can help your brand stand out.

Report Authored By:

Danielle Drayton, PhD

President & Founder

REACH Market Research

reach_logo